Evaluating thyme extract effect on clinical symptoms of children with allergic

Phase 3

• Conditions: Allergic rhinitis.; Other allergic rhinitis; J30.8

• Registration Number: IRCT20150426021944N3
• Lead Sponsor: Oroumia University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 3 April 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

Age lower than 12 years old
The use of thyme medicine and intranasal spray are excellent

Exclusion Criteria

Not using thyme medicine and Mumtazoon intranasal spray
Patients with non-allergic rhinitis
Children with moderate to severe drug side effects
Children suffering from other systemic diseases such as sinusitis and vautitis

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Duration of hospitalization. Timepoint: Duration of treatment. Method of measurement: Length of hospitalization.

Secondary Outcome Measures

Name	Time	Method
Medical allergy. Timepoint: Duration of treatment. Method of measurement: Clinical observations.